MIR17HG and central nervous system cancer: To validate whether MIR17HG could bind to miR-153 and miR-377 and regulate their expression, we first determined the expression of miR-153 and miR-377 in glioma-conditioned ECs (GECs) after silencing of MIR17HG (Fig. 5a).